Clinical Trials List
2023-12-01 - 2027-12-31
Phase III
Recruiting9
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chen-Teng Wu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- HWEI-CHUNG WANG Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEI-LI MA Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Hsin-Yu Liu Division of Ophthalmology
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 羅喬 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭懿萱 Division of Ophthalmology
- Chun-Yu Liu Division of Cardiovascular Diseases
- Chi-Cheng Huang Division of General Surgery
- 林燕淑 Division of General Surgery
- 馮晉榮 Division of General Surgery
- 賴亦貞 Division of Radiology
- 邱仁輝 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 陳彥蓁 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高婉真 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 甘蓉瑜 Division of General Surgery
- 徐旭亮 Division of Ophthalmology
- Fang-Ming Chen Division of General Surgery
- Chung-Liang Li Division of General Surgery
- 高理鈞 Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
- 高捷妮 Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張平穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 廖國秀 Division of General Surgery
- 吳宜穎 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 陳昱光 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
510 participants
